Literature DB >> 9159564

Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.

D E Newby1, D G Sciberras, C M Mendel, B J Gertz, N A Boon, D J Webb.   

Abstract

AIMS: The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man.
METHODS: On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography.
RESULTS: Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of < or = 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of > or = 16 pmol min(-1).
CONCLUSIONS: Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159564      PMCID: PMC2042777          DOI: 10.1046/j.1365-2125.1997.00583.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.

Authors:  D E Newby; F N Witherow; R A Wright; P Bloomfield; C A Ludlam; N A Boon; K A A Fox; D J Webb
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 2.  Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link?

Authors:  Stanley Chia; David E Newby
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

3.  NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs.

Authors:  Nadia M J Rupniak; Mary Katofiasc; Lesley Marson; Karl B Thor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-26       Impact factor: 3.000

4.  Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.

Authors:  Floris H M Vanmolkot; Jan N J M de Hoon
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

5.  Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man.

Authors:  D E Newby; D G Sciberras; C J Ferro; B J Gertz; D Sommerville; A Majumdar; R C Lowry; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

6.  Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.

Authors:  Jessica K Devin; Mias Pretorius; Hui Nian; Chang Yu; Frederic T Billings; Nancy J Brown
Journal:  Hypertension       Date:  2014-02-10       Impact factor: 10.190

7.  Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography.

Authors:  Fiona E Strachan; David E Newby; David G Sciberras; Jacqueline B McCrea; Michael R Goldberg; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

8.  Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury.

Authors:  Christian M Pedersen; Sowmya Venkatasubramanian; Henrik Vase; Janus A Hyldebrandt; Hussain Contractor; Michael R Schmidt; Hans Erik Bøtker; Nicholas L Cruden; David E Newby; Rajesh K Kharbanda; Ninian N Lang
Journal:  Br J Clin Pharmacol       Date:  2016-03-10       Impact factor: 4.335

9.  Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.

Authors:  Christian M Pedersen; Gareth Barnes; Michael R Schmidt; Hans Erik Bøtker; Rajesh K Kharbanda; David E Newby; Nicholas L Cruden
Journal:  Eur Heart J       Date:  2011-10-11       Impact factor: 29.983

10.  Vascular effects of urocortins 2 and 3 in healthy volunteers.

Authors:  Sowmya Venkatasubramanian; Megan E Griffiths; Steven G McLean; Mark R Miller; Rosa Luo; Ninian N Lang; David E Newby
Journal:  J Am Heart Assoc       Date:  2013-01-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.